Lundbeck Notches Win In Danish Cipralex Case

Law360, New York (April 16, 2010, 2:36 PM EDT) -- Danish drug maker H. Lundbeck A/S has scored a ruling in its favor in one case but was dealt a setback in another in disputes with companies seeking to market generic versions of its antidepressant Cipralex.

Lundbeck said in a Friday statement that it was notified of a “favorable ruling” in a preliminary injunction case against wholesaler Pharmachange in the City Court in Elsinore in Denmark, which held that generic versions of escitalopram have to be removed from the Danish market.

That ruling can be appealed...
To view the full article, register now.